News Story: Full Text
Sponsored By
Gleolan for brain tumors
Please Click On The Above Banner For More Details
Braintumor Website


No OS Boost With Opdivo in Recurrent Glioblastoma

Al's Comment:

 This study shows that using Opdivo by itself doesn't work well in recurrent glioblastoma. My thoughts are that something else is needed to trigger the immune response, then Opdivo can enhance that response.   It might be something as simple as Optune - by killing cells, neoantigens are released and the immune system gets primed. Opdivo could theoretically enhance that immune response. Or a vaccine. Or more radiation.  These things need to be tested further!

Posted on: 05/21/2020

No OS Boost With Opdivo in Recurrent Glioblastoma


Click HERE to return to brain tumor news headlines

Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2020 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557